期刊文献+

肺炎嗜衣原体感染与动脉粥样硬化的关系 被引量:3

下载PDF
导出
摘要 本文介绍了肺炎嗜衣原体感染与动脉粥样硬化的关系、肺炎嗜衣原体在体内的传播及其与血管内皮细胞、单核/巨噬细胞、平滑肌细胞之间的相互作用,以及肺炎嗜衣原体感染对动脉粥样硬化斑块稳定性的影响和肺炎嗜衣原体感染致动脉粥样硬化的机制。
出处 《中国动脉硬化杂志》 CAS CSCD 2008年第4期332-334,共3页 Chinese Journal of Arteriosclerosis
  • 相关文献

参考文献20

  • 1Kaperonisa EA,Liapisa CD,Kakisisb JD,et al.Inflammation and Atherosclerosis[J].Eur J Vasc Endovasc Surg,2006 , 31( 4 ) : 386-393 .
  • 2Cochrane M,Walker P,Gibbs H,et al.Multiple genotypes of Chlamydia pneumoniae identified in human carotid plaque[J].Microbiology,2000,146(7):1651-660.
  • 3Grayston JT,Kuo CC,Wang SP,et al.A new Chlamydia psittaci strain,TWAR isolated in acute respiratory tract infections [J]. N Engl J Med, 1986, 315 (3): 161-168.
  • 4Jha HC,Vardhan H,Gupta R,et al.Higher incidence of presistent chronic infection of Chlamydia pneumoniae among coronary artery disease patients in India is a cause of concern[J]. BMC Infect Dis, 2007, 30 (7) : 42-48.
  • 5董吁钢,孙晓欣,宁波.急性冠脉综合征患者血清肺炎衣原体、人巨细胞病毒感染的血清学研究[J].岭南心血管病杂志,2000,6(4):237-239. 被引量:7
  • 6Margareta M,Ieven Vicky Y,Hoymans.Involvement of chlamydia pneumoniae in Atherosclerosis:More Evidence for Lack of Evidence [ J ]. J Microbiol, 2005, 43 (1): 19-24.
  • 7Ramirez JA. Isolation of Cldamydia pneumoniae from the coronary artery of patient with coronary atherosclerosis [J]. Ann Intern Med, 1996, 125 (12): 979- 952.
  • 8吴红军,曾秋棠.组织因子与冠状动脉疾病[J].中国动脉硬化杂志,2003,11(5):481-483. 被引量:2
  • 9Fong IW, Chiu B,Viira E,et al.Rabit model for Chlamydia pneumoniae infection[J].J Clin Microbiol,1997, 35 (1): 48-52.
  • 10Hillis GS,Pearson CV,Harding SA,et al.Effects of a brief course of azithromycin on soluble cell adhesion molecules and markets of inflammation in survivors of an acute coronary syndrome:A double -blind,randomized,placebo-controlled study[J].Am Heart J, 2004,148(1):72-79.

二级参考文献32

  • 1李帮清,徐成斌,王琼,尹协瑛.冠状动脉粥样硬化性心脏病患者血清抗人巨细胞病毒抗体检测[J].中华内科杂志,1996,35(11):741-743. 被引量:12
  • 21,Blasi F, Cosentini R, Raccanelli R, et al. A possible association of Chlamydia pneumoniae infection and acute myocardial infarction in patients younger than 65 years of age. Chest, 1997, 112(2):309~312
  • 32,Saikku P, Mattila K, Nieminen MS, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet, 1988, Ⅱ:983~986
  • 43,Mendall MA, Carrington D, Strachan D, et al. Chlamydia pneumoniae:risk factors for seropositivity and association with coronary heart disease. J Infect, 1995, 30(2):121~128
  • 54,Wong YK, Gallagher PJ, Ward ME. Chlamydia pneumoniae and atherosclerosis. Heart, 1999, 81:232~238
  • 67,Grayston JT, Campbell LA, Kuo CC, et al. A new respiratory tract pathogen:Chlamydia pneumoniae strain TWAR. J Infect Dis, 1990, 161(4):618~625
  • 78,Grayston JT, Kuo CC, Campbell LA, et al. Chlamydia pneumoniae strain TWAR and atherosclerosis. Eur Heart J, 1993, 14(Suppl K):66~71
  • 89,Bauriedel G, Schmucking I, Hutter R, et al. Evidence of Chlamydia pneumoniae in human arteriosclerotic Lesions:Insights into its possible pathogenic role. J Am Coll Cardiol, 1998, 31:A390~391
  • 910,Hendrix MG, Daemen M, Bruggeman CA. Cytomegalovirus nucleic acid distribrtion within the human vascular tree. Am J Pathol, 1991, 138(3):563~567
  • 10Ardissino D, Merlini PA, Bauer KA, Bramucci E,Ferrario M, Coppola R, et al. Thrombogenie potential of human coronary atherosclerotic plaques. Blood,2001. 98(9) : 2 726-729.

共引文献7

同被引文献25

  • 1Thomas M,File JR. The science of selecting antimicrobials for community-acquired pneumonia(CAP)[J].JOURNAL OF MANAGED CARE PHARMACY,2009,(02):S5-S11.
  • 2Burgher D P, Sabin M A, Magnussen C G, et al. Early childhood hospitalisation with infection and subclinical atherosclerosis in adulthood: The Cardiovascular Risk in Young Finns Study. Atherosclerosis, 2015, 239(2): 496-502.
  • 3Watson C, Alp N J. Role of Chlamydia pneumoniae in atherosclerosis. Clin Sci (Lond), 2008, 114(8): 509-531.
  • 4Chen J, Zhu M, Ma G, et ol. Chlamydia pneumonioe infection and cerebrovascular disease: a systematic review and meta-analysis. BMC Neurol, 2013, 13:183.
  • 5Zhao G J, Yin K, Fu Y C, et 0l. The interaction of ApoA-I and ABCA1 triggers signal transduetion pathways to mediate effiux of cellular lipids. Mol Med, 2012, 18 (1): 149-158.
  • 6Roblin P M, Dumomay W, Hammerschlag M R. Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol, 1992, 30(8): 1968-197l.
  • 7He P P, Ouyang X P, Tang Y Y, et ol. MicroRNA-590 attenuates lipid accumulation and pro-inflammatory cytokine secretion by targeting lipoprotein lipase gene in human THP-1 macrophages. Bioehimie, 2014, 106:81-90.
  • 8Mo Z C, Xiao J, Tang S L, et al. Advanced oxidation protein products exacerbates lipid accumulation and atherosclerosis through downregulation of ATP-binding cassette transporter A1 and G1 expression in apolipoprotein E knockout mice. Circ J, 2014, 78 (11): 2760-2770.
  • 9Kodama T, Freeman M, Rohrer L, et ol. Type I maerophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature, 1990, 343 (6258): 531-535.
  • 10Adorni M P, Zimetti F, BiUheimer J T, et ol. The roles of different pathways in the release of cholesterol from macrophages. J Lipid Res, 2007, 48 (11): 2453-2462.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部